Figure 2. Forest Plot of Progression-free Survival in Prespecified Subgroups.
Hazard ratios of less than 1.00 for disease progression or death indicate better results in the idelalisib group.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.